Observational studyESMO open2022

Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study.

G Procopio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.